Everence Capital Management Inc Medifast Inc Transaction History

Everence Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$103.38 - $126.05 $184,016 - $224,369	1,780 New	1,780 $205,000
Q1 2022 Apr 11, 2022	SELL	$163.59 - $219.02 $103,061 - $137,982	-630 Reduced 26.14%	1,780 $304,000
Q4 2021 Jan 28, 2022	BUY	$185.81 - $230.36 $113,344 - $140,519	610 Added 33.89%	2,410 $505,000
Q1 2021 Apr 06, 2021	SELL	$192.6 - $274.3 $98,226 - $139,893	-510 Reduced 22.08%	1,800 $381,000
Q3 2020 Feb 01, 2021	BUY	$141.27 - $182.68 $326,333 - $421,990	2,310 New	2,310 $380,000
Q3 2019 Oct 09, 2019	SELL	$98.06 - $122.99 $173,566 - $217,692	-1,770 Closed	0 $0
Q3 2018 Oct 22, 2018	SELL	$158.99 - $255.94 $85,854 - $138,207	-540 Reduced 23.38%	1,770 $392,000
Q1 2018 Apr 30, 2018	BUY	$63.32 - $93.45 $146,269 - $215,869	2,310 New	2,310 $216,000

171

9.97M

554K

545K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $214M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.